表紙：裂肛治療の市場規模、シェア、成長分析、治療タイプ別、用途別、投与経路別、地域別 - 産業予測、2025年～2032年

市場調査レポート

商品コード

1789220

裂肛治療の市場規模、シェア、成長分析、治療タイプ別、用途別、投与経路別、地域別 - 産業予測、2025年～2032年

Anal Fissure Treatment Market Size, Share, and Growth Analysis, By Treatment Types (Topical Nitroglycerin, Calcium channel Blockers), By Application (Clinics, Hospitals), By Route of Administration, By Region - Industry Forecast 2025-2032

出版日: 2025年08月08日
発行: SkyQuest
ページ情報: 英文 182 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 789,170円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 923,180円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,057,190円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.90円

全表示
概要
目次

概要

サンプル依頼リストに入れる

裂肛治療の世界市場規模は2023年に13億8,000万米ドルと評価され、2024年の14億3,000万米ドルから2032年には102億米ドルに成長し、予測期間（2025-2032年）のCAGRは18.20%で成長する見通しです。

世界の裂肛治療市場は、胃腸に対する意識の高まりと肛門疾患の増加によって大きな成長を遂げています。低侵襲手術技術の進歩や新規局所薬の導入により、患者の治療選択肢は広がっています。さらに、遠隔医療とオンラインヘルスプラットフォームの統合により、専門医による診察とフォローアップへのアクセスが改善され、患者の転帰と満足度の向上につながっています。患者のQOL（生活の質）を優先する顕著な動向は、ボツリヌス毒素注射や革新的な局所薬が最小限の回復時間で効果的な症状緩和を提供することで、外来治療や非外科的治療へのシフトを促しています。しかし、同市場は、電子カルテや遠隔医療サービスへの依存度が高まる中で、患者の機密保持やデータセキュリティの確保という課題に直面しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Cipla Inc.
Boehringer Ingelheim International GmbH
Geri-Care Pharmaceuticals Corp.
AbbVie Inc.
Novartis AG
Teva Pharmaceuticals
Troikaa Pharmaceuticals Ltd.
RDD Pharma Ltd.
Kyowa Kirin Co., Ltd.
Ipsen Pharma
Sanofi S.A.
Bliss GVS
SRS Life Sciences Inc.
Healthy Life Pharma Private Limited
Bayer AG

結論と提言

Product Code: SQMIG35D2343

Global Anal Fissure Treatment Market size was valued at USD 1.38 Billion in 2023 and is poised to grow from USD 1.43 Billion in 2024 to USD 10.20 Billion by 2032, growing at a CAGR of 18.20% in the forecast period (2025-2032).

The global anal fissure treatment market has experienced significant growth, fueled by heightened gastrointestinal awareness and a rise in anorectal disorders. Advances in minimally invasive surgical techniques and the introduction of novel local medications have broadened treatment options for patients. Additionally, the integration of telemedicine and online health platforms has improved access to specialist consultations and follow-ups, leading to enhanced patient outcomes and satisfaction. A notable trend towards prioritizing patient quality of life has prompted a shift toward outpatient care and non-surgical treatments, with botulinum toxin injections and innovative local agents offering effective symptom relief with minimal recovery time. However, the market faces challenges in maintaining patient confidentiality and data security in the context of increased reliance on electronic health records and telehealth services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Anal Fissure Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Anal Fissure Treatment Market Segments Analysis

The global anal fissure treatment marketis segmented into treatment type, route of administration, application, and region. By treatment type, the market is classified into topical nitroglycerin, calcium channel blockers, stool softeners, and others. Depending on the application, it is divided into clinics, hospitals, and others. According to route of administration, the market is categorized into topical and oral routes. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Anal Fissure Treatment Market

A significant factor driving the growth of the anal fissure treatment market is the increasing prevalence of gastrointestinal disorders, including inflammatory bowel disease and constipation. As these conditions become more common, especially among the aging population, the occurrence of anal fissures is also on the rise. Contributing lifestyle and dietary factors further exacerbate these gastrointestinal issues, leading to a higher demand for effective treatments. Additionally, the growing elderly demographic, which is more vulnerable to conditions that result in sphincter thinning and tissue tearing, is expected to sustain the demand for affordable treatment options, thereby stimulating market expansion.

Restraints in the Global Anal Fissure Treatment Market

While the global market for anal fissure treatment is experiencing growth, several constraints hinder its full potential, particularly in developing regions. Limited awareness surrounding the symptoms and available treatments significantly impacts patient care, as many physicians may hesitate to refer patients due to embarrassment or a lack of knowledge regarding the condition. This often results in underdiagnosis and inadequate treatment, allowing fissures to progress into chronic issues that require more complex and expensive interventions. Additionally, insufficient public education efforts and inadequate healthcare infrastructure in certain areas further impede timely diagnosis and access to effective treatments.

Market Trends of the Global Anal Fissure Treatment Market

The Global Anal Fissure Treatment market is increasingly leaning towards minimally invasive approaches and innovative therapeutic options. A significant surge in demand for less intrusive interventions, such as botulinum toxin injections and advanced topical medications, reflects a shift from conventional surgical methods. This trend is driven by the benefits of quicker recovery times, lower incidence of complications, and enhanced patient convenience, all of which contribute to higher compliance and satisfaction rates. As healthcare providers and patients alike prioritize effective yet gentle treatment solutions, the market is poised for growth marked by the adoption of cutting-edge therapies and improved drug delivery systems.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Case Studies
Customer Buying Behavior Analysis

Global Anal Fissure Treatment Market Size by Treatment Types & CAGR (2025-2032)

Market Overview
Topical Nitroglycerin
Calcium channel Blockers
Stool Softeners
Other

Global Anal Fissure Treatment Market Size by Application & CAGR (2025-2032)

Market Overview
Clinics
Hospitals
Other

Global Anal Fissure Treatment Market Size by Route of Administration & CAGR (2025-2032)

Market Overview
Topical
Oral Routes

Global Anal Fissure Treatment Market Size & CAGR (2025-2032)

North America (Treatment Types, Application, Route of Administration)
- US
- Canada
Europe (Treatment Types, Application, Route of Administration)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Treatment Types, Application, Route of Administration)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Treatment Types, Application, Route of Administration)
- Brazil
- Rest of Latin America
Middle East & Africa (Treatment Types, Application, Route of Administration)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Cipla Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Geri-Care Pharmaceuticals Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Troikaa Pharmaceuticals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RDD Pharma Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kyowa Kirin Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ipsen Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bliss GVS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SRS Life Sciences Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Healthy Life Pharma Private Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

裂肛治療の市場規模、シェア、成長分析、治療タイプ別、用途別、投与経路別、地域別 - 産業予測、2025年～2032年

Anal Fissure Treatment Market Size, Share, and Growth Analysis, By Treatment Types (Topical Nitroglycerin, Calcium channel Blockers), By Application (Clinics, Hospitals), By Route of Administration, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

裂肛治療市場規模：治療タイプ別& CAGR（2025-2032）

裂肛治療市場規模：用途別& CAGR（2025-2032）

裂肛治療市場規模：投与経路別& CAGR（2025-2032）

裂肛治療市場規模：地域別& CAGR（2025-2032）